🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and efficacy of ropivacai...
Status
Completed
Location
Weill Medical College of Cornell University
Start Date
2022-11-10
Trial ID
NCT05544734
Treatments Being Tested
This is an observational, longitudinal, prospective study for sample collec...
Status
Active Not Recruiting
Location
Institute of Human Virology, University of Maryland School of Medicine
Start Date
2014-12
Trial ID
NCT02995252
The purpose of this clinical trial is to find out whether one type of fish ...
Status
Not Yet Recruiting
Location
Institut de recherches cliniques de Montréal (IRCM)
Start Date
2026-07
Trial ID
NCT07575438
Treatments Being Tested
RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Status
Completed
Location
Roswell Park Cancer Institute
Start Date
2008-10
Trial ID
NCT00509093
RATIONALE: Erlotinib may stop the growth of tumor cells by blocking some of...
Status
Completed
Location
University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center
Start Date
2007-11-19
Trial ID
NCT00720304
Treatments Being Tested
The main goal is to reveal differences in global gene expression in two dif...
Status
Active Not Recruiting
Location
AdventHealth Translational Research Institute
Start Date
2020-01-31
Trial ID
NCT04034706
This is an open-label, multicenter, Phase Ib, dose-escalation and cohort-ex...
Status
Completed
Location
UCLA
Start Date
2012-08-13
Trial ID
NCT01656642
Treatments Being Tested
This phase II trial tests how well giving dasatinib and quercetin with cycl...
Status
Recruiting
Location
Mayo Clinic in Rochester
Start Date
2025-09-18
Trial ID
NCT06940297
This study assess the genomics profiles in synovial biopsies obtained prior...
Status
Completed
Location
Adrien NZEUSSEU TOUKAP
Start Date
2020-11-12
Trial ID
NCT04645420
Treatments Being Tested
This phase II trial tests how well decitabine and cedazuridine (DEC-C) work...
Status
Terminated
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-04-13
Trial ID
NCT05799079
Treatments Being Tested